Mundipharma GmbH
- Pharmaceutical Sales 2009
-
in Germany (and worldwide): 268 million Euro
- Product Range
- Pain therapy (severe pain), cancer (non-Hodgkin's lymphoma, chronic lymphatic leukaemia, multiple myeloma, meningeosis lymphomatosa), wound healing, bacterial infections, respiratory diseases
- Key Research Areas
- Pain; bone and joint diseases; cancer (antineoplastic therapy to treat solid tumors, antineoplastic therapy to treat hematologic tumors), neurologic diseases; orphan diseases, respiratory diseases (asthma, COPD), substitution therapy
- R&D Expenditure 2009
-
in Germany (and worldwide): 20 percent of total revenue
- Employees in the Pharmaceuticals Division 2009
-
In Germany (and worldwide): 900
(All data based on corporate information, as of: 05/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page